Replies to post #19060 on Intellipharmaceutics International Inc. (IPCI)

[Noodle2]

Price action before and after the Oct, 11, 2016 "Exclusive and Commercial Supply Agreement with Mallinckrodt.

Date Open High Low Close Adj Cl Vol.

Oct 26, 2016 3.00 3.00 2.81 2.90 2.90 198,600
Oct 25, 2016 3.05 3.07 2.96 2.98 2.98 168,900
Oct 24, 2016 3.16 3.20 2.96 3.05 3.05 579,700
Oct 21, 2016 3.01 3.19 2.97 3.15 3.15 925,900
Oct 20, 2016 2.81 3.02 2.79 3.01 3.01 531,900
Oct 19, 2016 2.70 2.96 2.61 2.86 2.86 733,900
Oct 18, 2016 2.80 2.80 2.64 2.67 2.67 336,500
Oct 17, 2016 2.88 2.88 2.70 2.75 2.75 355,100
Oct 14, 2016 2.99 2.99 2.73 2.86 2.86 675,600
Oct 13, 2016 3.05 3.08 2.72 2.90 2.90 766,600
Oct 12, 2016 3.18 3.33 2.91 2.98 2.98 3,035,900
Oct 11, 2016 2.65 2.83 2.54 2.83 2.83 1,252,000
Oct 10, 2016 2.80 3.14 2.76 2.84 2.84 7,504,200
Oct 07, 2016 2.29 2.40 2.22 2.38 2.38 424,100
Oct 06, 2016 2.21 2.33 2.12 2.24 2.24 253,000
Oct 05, 2016 2.17 2.19 2.10 2.19 2.19 107,700
Oct 04, 2016 2.35 2.40 2.11 2.14 2.14 441,800
Oct 03, 2016 2.14 2.36 2.08 2.25 2.25 587,800
Sep 30, 2016 2.05 2.10 2.00 2.10 2.10 190,400
Sep 29, 2016 2.03 2.06 1.98 2.00 2.00 127,300
Sep 28, 2016 2.12 2.12 1.89 2.03 2.03 467,500
Sep 27, 2016 2.23 2.23 2.02 2.09 2.09 220,400
Sep 26, 2016 2.06 2.25 2.05 2.21 2.21 342,600
Sep 23, 2016 2.00 2.24 2.00 2.11 2.11 1,012,800
Sep 22, 2016 1.85 2.34 1.83 2.30 2.30 1,521,100

On Oct, 7, 2016, IPCI "received tentative approval from the U.S. Food and Drug Administration ("FDA") for the Company's abbreviated new drug application ("ANDA") for quetiapine fumarate extended-release tablets in the 50, 150, 200, 300 and 400 mg strengths."

http://www.intellipharmaceutics.com/releasedetail.cfm?ReleaseID=992728

On Oct, 13, 2016, IPCI's 3Q came out and it was a miss and the stock slid, only to come back into the $3 range for a few days near the time of the NDA app. for Rexista was submitted (Nov 25). Let's hope for the $3 range and more next time. I doubt it will last once the shorts get back into business.